Forum

Delayed hypersensitivity to low molecular weight heparin (LMWH) in pregnancy

Elise Schapkaitz, barry frank jacobson

Abstract


Heparin is currently the anticoagulant of choice for the prevention and treatment of thrombo-embolic disease in pregnancy because it does not cross the placenta [1]. The use of low molecular weight heparin (LMWH) is preferred to unfractionated heparin (UFH) as it is associated with a lower risk of bleeding, osteoporosis, heparin induced thrombocytopenia (HIT) and hypersensitivity reactions [2, 3, 4, 5]. Fondaparinux can be considered as a valuable alternative to LMWH during pregnancy in those patients with heparin induced skin reactions and/or HIT.

Authors' affiliations

Elise Schapkaitz, NHLS/WITS

barry frank jacobson, NHLS

Full Text

PDF (1431KB)

Keywords

heparin; allergy

Cite this article

South African Medical Journal 2007;97(12):1255.

Article History

Date submitted: 2007-06-18
Date published: 2007-10-17

Article Views

Abstract views: 2043
Full text views: 1719

Comments on this article

*Read our policy for posting comments here